Clinical Study
Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma
Table 2
Adverse events at least possibly related to treatment.
| Toxicity | Grade | 1/2 | 3 | 4 | Total |
| Headaches | 2 | 0 | 0 | 2 | Fatigue | 2 | 0 | 0 | 2 | Muscle pain | 1 | 0 | 0 | 1 | Injection site reaction | 6 | 0 | 0 | 6 | Induration | 1 | 0 | 0 | 1 | Flushing | 1 | 0 | 0 | 1 | Flu-like symptoms | 1 | 0 | 0 | 1 | Pruritus | 1 | 0 | 0 | 1 | Deep vein thrombosis | 0 | 1 | 0 | 1 | Hyperbilirubinemia | 1 | 0 | 0 | 1 | Elevated alkaline phosphatase | 1 | 0 | 0 | 1 | Proteinuria | 1 | 0 | 0 | 1 |
| Total | 18 | 1 | 0 | 19 |
|
|